Ascending cholangitis cost-effectiveness of therapy: Difference between revisions
Created page with "__NOTOC__ {{Ascending cholangitis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{re..." |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 2: | Line 2: | ||
{{Ascending cholangitis}} | {{Ascending cholangitis}} | ||
{{CMG}}; {{AE}} {{AHS}} | |||
== Overview == | |||
Early [[Endoscopic retrograde cholangiopancreatography|ERCP]] is considered safe as well as cost-effective in the treatment of mild to moderate ascending cholangitis | |||
== Cost effectiveness of therapy for ascending cholangitis == | |||
According to some studies, early [[Endoscopic retrograde cholangiopancreatography|ERCP]] is considered safe as well as cost effective in the treatment of mild to moderate ascending cholangitis. It reduces the duration of hospital stay and antibiotics are needed for fewer days thus making it a cost effective intervention<ref name="AlperUnsal2011">{{cite journal|last1=Alper|first1=Emrah|last2=Unsal|first2=Belkis|last3=Buyraç|first3=Zafer|last4=Baydar|first4=BehlüL.|last5=Aslan|first5=Fatih|last6=Akça|first6=Serdar|last7=Ustundag|first7=Yucel|title=Sa1520 Early ERCP Is Safe and Cost-Effective in the Treatment of Mild to Moderate Acute Cholangitis|journal=Gastrointestinal Endoscopy|volume=73|issue=4|year=2011|pages=AB195|issn=00165107|doi=10.1016/j.gie.2011.03.254}}</ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Needs content]] | [[Category: Needs content]] | ||
Latest revision as of 17:37, 9 October 2018
|
Ascending cholangitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ascending cholangitis cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Ascending cholangitis cost-effectiveness of therapy |
|
Ascending cholangitis cost-effectiveness of therapy in the news |
|
Blogs on Ascending cholangitis cost-effectiveness of therapy |
|
Risk calculators and risk factors for Ascending cholangitis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anila Hussain, MD [2]
Overview
Early ERCP is considered safe as well as cost-effective in the treatment of mild to moderate ascending cholangitis
Cost effectiveness of therapy for ascending cholangitis
According to some studies, early ERCP is considered safe as well as cost effective in the treatment of mild to moderate ascending cholangitis. It reduces the duration of hospital stay and antibiotics are needed for fewer days thus making it a cost effective intervention[1]
References
- ↑ Alper, Emrah; Unsal, Belkis; Buyraç, Zafer; Baydar, BehlüL.; Aslan, Fatih; Akça, Serdar; Ustundag, Yucel (2011). "Sa1520 Early ERCP Is Safe and Cost-Effective in the Treatment of Mild to Moderate Acute Cholangitis". Gastrointestinal Endoscopy. 73 (4): AB195. doi:10.1016/j.gie.2011.03.254. ISSN 0016-5107.